The Silent Interval: Organ Perfusion Data, Patient Rights, and the Case for Advocacy-Led Governance of Organ Preservation
Between the moment a kidney is recovered and the moment it is either implanted or discarded lies an interval that patients never see and rarely hear about. During this interval, decisions about how an organ is preserved, how long it waits, how its quality is judged, and whether it is ultimately used are made almost entirely without patient knowledge or input. Machine perfusion has begun to change the science of that interval. It can sustain organs beyond static storage and, particularly under metabolically active conditions, generate real-time measures of organ function that may inform viability assessment. Yet the data these systems produce remain incompletely standardized, inconsistently recorded across protocols, and largely invisible to the people whose lives depend on them. This paper argues that the advance of perfusion technology and the advance of patient advocacy are not parallel efforts but a single, interdependent agenda: the more an organ can be measured, the stronger the ethical obligation to make those measurements transparent, comparable, traceable, and appropriately accessible. Drawing on a Lean Six Sigma process framework, the paper maps the preservation pathway as a sequence of measurable steps, identifies points at which information can be lost, and examines how non-transparent organ-quality judgments may contribute to discard decisions. It then considers how emerging oxygen-delivery platforms, including biological hemoglobin oxygen carriers, may support objective viability assessment, while emphasizing that evidence is product-, organ-, temperature-, and protocol-specific and cannot be generalized across an entire class. The paper closes with advocacy-driven recommendations: standardized reporting of preservation time and perfusion parameters, inclusion of key preservation data in the transplant record, patient-centered endpoints in perfusion research, and formal patient representation in the oversight of new preservation technologies. The central claim is straightforward: innovation in organ preservation will deliver its full value only when the silent interval is no longer silent.
Authors
- Archil Jaliashvili (ORCID: https://orcid.org/0009-0006-4712-4942)
- Jeff A. Parke
Publication Details
- Journal
- Preprints.org
- Published
- 2026-11-13
- DOI
- https://doi.org/10.20944/preprints202611.1378.v1
- Primary Topic
- Organ Donation and Transplantation
- Type
- preprint